Though stakeholders largely unclear on specifics . . .

Trump Budget Language On Value-Based Payment Appears In Line With Consensus Proposals Unveiled Last Week

May 23, 2017 at 6:28 PM
The Trump administration pledged in its 2018 budget to offer more clarity on use of value-based payment and to foster the exchange of preapproval information between industry and payers, which two industry groups view as tracking with a drug pricing policy slate unveiled by a coalition of drug makers and payers last week. Policy watchers told Inside Health Policy that the administration's vaguely worded promise on value-based pay could signify a move toward shielding such arrangements from anti-kickback and Stark...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.